Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NO/redox disequilibrium in the failing heart and cardiovascular system
Joshua M. Hare, Jonathan S. Stamler
Joshua M. Hare, Jonathan S. Stamler
View: Text | PDF
Review Series

NO/redox disequilibrium in the failing heart and cardiovascular system

  • Text
  • PDF
Abstract

There is growing evidence that the altered production and/or spatiotemporal distribution of reactive oxygen and nitrogen species creates oxidative and/or nitrosative stresses in the failing heart and vascular tree, which contribute to the abnormal cardiac and vascular phenotypes that characterize the failing cardiovascular system. These derangements at the integrated system level can be interpreted at the cellular and molecular levels in terms of adverse effects on signaling elements in the heart, vasculature, and blood that subserve cardiac and vascular homeostasis.

Authors

Joshua M. Hare, Jonathan S. Stamler

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
NO/redox-based signaling and nitrosative stress. Molecular recognition b...
NO/redox-based signaling and nitrosative stress. Molecular recognition by cysteine-containing proteins is achieved either through the existence of single classes of thiols that are adapted to differentiate NO modification (S-nitrosylation) from oxidations (S-glutathionylation, S-S [intramolecular disulfide] and/or sulfur oxides [SOx–, where x is 1–3]) – exemplified in protein 1 – or through the presence of multiple classes of thiols, each adapted to recognize different redox-related molecules, including NO, GSNO, H2O2, O2, and cellular redox potential (for protein 2, note that some classes of thiols may be functionally linked to others, exemplified in the pO2-dependent oxidation of RyR thiols that promotes S-nitrosylation). In model 1, thiol oxidation would adversely impact nitrosylation signaling. In model 2, signal malfunction may result from altered amounts, timing, and/or the nature of RNS/ROS-based modifications. S, cysteine thiol; GSH/GSSG, glutathione/glutathione disulfide; pO2, partial pressure of O2.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts